Publication | Closed Access

The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease

Alzheimer's DiseaseMedicineDementiaImmunologyVascular DementiaLate Onset AlzheimerAlpha-2-macroglobulin Serum LevelsNeurochemical BiomarkersNeuroscienceNeurologyMild Cognitive ImpairmentNeurodegenerationAging-associated DiseaseNeuroimmunology